Catabasis Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$4.25 |
Market Cap |
$85.76 M |
Shares Outstanding |
11.5 M |
Public Float |
10.43 M |
Address |
One Kendall Square Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.catabasis.com |
Updated | 07/08/2019 |
Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of therapeutics for the treatment of cardiovascular, metabolic and inflammatory diseases. The company was founded by Jill C. |